Akers Biosciences Inc (NASDAQ:AKER) released its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.13) EPS for the quarter, Yahoo Finance reports. Akers Biosciences had a negative return on equity of 59.94% and a negative net margin of 89.49%.

Akers Biosciences (NASDAQ:AKER) opened at $0.64 on Thursday. Akers Biosciences has a 52-week low of $0.61 and a 52-week high of $3.05.

WARNING: “Akers Biosciences Inc (AKER) Issues Earnings Results” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://theolympiareport.com/2017/11/16/akers-biosciences-inc-aker-issues-earnings-results.html.

Akers Biosciences Company Profile

Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States and internationally. The company’s marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.

Earnings History for Akers Biosciences (NASDAQ:AKER)

Receive News & Ratings for Akers Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.